4-HO-McPT Stats & Data

Extremely limited human data exist for 4-HO-McPT; treat all dose and duration guidance as tentative and titrate cautiously with a milligram scale. Anecdotal reports suggest a relatively brief and sometimes wave-like course orally, with some users noting mild rebound headaches; plan set, setting, and next-day commitments accordingly. Given the scarcity of pharmacokinetic data, avoid redosing quickly, as delayed absorption or batch variability could cause unexpectedly strong effects. Several users describe severe nasal burn and irritation with insufflation; oral use is the least caustic known route and is the default for most 4-hydroxy tryptamines. As with other serotonergic psychedelics, avoid combining with lithium due to a substantially increased seizure risk observed when classic psychedelics are taken with lithium; this applies even at therapeutic lithium levels. MAOIs can markedly potentiate tryptamines and increase risks (e.g., hypertensive reactions and serotonin toxicity), so this combination should be strictly avoided outside clinical settings. Tramadol lowers seizure threshold and has serotonergic activity; combining with psychedelics increases seizure and adverse neuropsychiatric risk and should be avoided. Stimulants (e.g., amphetamines, cocaine) can amplify anxiety, cardiovascular strain, and thought loops; avoid or use extreme caution if you have any cardiovascular, anxiety, or panic history. SSRIs/SNRIs often blunt the subjective effects of psychedelics but can still interact unpredictably; if on antidepressants, avoid DIY discontinuation and consult a clinician instead of mixing. Because unregulated markets frequently mislabel tryptamines (e.g., 4-HO-MET sold as psilocybin), use accredited drug checking where available, recognizing that at-home reagents are helpful but not definitive. Perform a low-dose allergy test with any new batch and use accurate scales; start at threshold if untested. Individuals with a personal or family history of seizures, serious cardiovascular disease, or current manic states should avoid experimental tryptamines like 4-HO-McPT. Have a sober, trusted sitter for first trials, avoid alcohol or sedatives to “manage” the trip, and seek medical help promptly for severe agitation, chest pain, uncontrolled vomiting, loss of consciousness, or convulsions.